
Taurocholic acid
CAS No. 81-24-3
Taurocholic acid( —— )
Catalog No. M31531 CAS No. 81-24-3
Taurocholic acid is a bile acid involved in the emulsification of fats.Taurocholic acid is cytoprotective, preventing tumor necrosis factor-alpha-induced cholangiocyte damage via a PI3K-mediated pathway.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 50 | In Stock |
![]() ![]() |
10MG | 73 | In Stock |
![]() ![]() |
50MG | Get Quote | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameTaurocholic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionTaurocholic acid is a bile acid involved in the emulsification of fats.Taurocholic acid is cytoprotective, preventing tumor necrosis factor-alpha-induced cholangiocyte damage via a PI3K-mediated pathway.
-
DescriptionTaurocholic acid is a bile acid involved in the emulsification of fats.Taurocholic acid is cytoprotective, preventing tumor necrosis factor-alpha-induced cholangiocyte damage via a PI3K-mediated pathway.
-
In VitroTaurocholic acid (100 μM, 24 h) decreases the proportion of CD3+CD8+ T and NK cells in isolated PBMCs from HBeAg-positive CHB patients.Taurocholic acid (100 μM, 24 h) decreases IFN-α stimulated cytokine and cytotoxic granule levels (IFN-γ, TNF-α, granzyme B) in CD3+CD8+ T and NK cells.
-
In VivoAnimal Model:C57BL/6 mice Dosage:100-mg/kg Administration:oral gavage, for 2 weeks after tail vein injection with rAAV8-1.3HBV for 6 weeks Result:Reduced the percentage of NK and CD3+CD8+ T cells.Increases serum HBsAg, HBeAg, and HBV DNA levels.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number81-24-3
-
Formula Weight515.7
-
Molecular FormulaC26H45NO7S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (193.91 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
RBC10
RBC10 inhibits the binding of Ral to its effector RALBP1, as well as inhibiting Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of human cancer cell lines.
-
GSK572A
GSK572A is a novel and potent potent inhibitor of EchA6, which can be used to treat tuberculosis.
-
Taurolidine
Taurolidine is a synthetic taurine analog with antimicrobial and anti-neoplastic actions.?It displays broad bactericidal and fungicidal activity.